Putnam Investments’s Zosano Pharma Corporation ZSAN Stock Holding History

Putnam Investments’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-571	Closed	-$528K	–	1375
2016 Q2	$528K	Hold	571	–	–	﹤0.01%	1187
2016 Q1	$920K	Hold	571	–	–	﹤0.01%	1131
2015 Q4	$892K	Hold	571	–	–	﹤0.01%	1183
2015 Q3	$1.58M	Hold	571	–	–	﹤0.01%	1051
2015 Q2	$2.9M	Hold	571	–	–	0.01%	935
2015 Q1	$4.04M	Buy	+571	New	+$4.28M	0.01%	839

Other funds holding ZSAN

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Putnam Investments's ZSAN Position: Q3 2016 in Review

Putnam Investments sold out of Zosano Pharma Corporation (ZSAN) in Q3 2016, closing a stake of 571 shares — an estimated $528K sold.

Putnam Investments first reported a position in ZSAN in Q1 2015 and held it in 6 quarters. The position peaked at $4.04M in Q1 2015. 14 funds tracked by Wall St. Rank hold ZSAN as of Q3 2016.

Putnam Investments reported no remaining Zosano Pharma Corporation position as of Q3 2016 after selling out during the quarter.
Putnam Investments sold 571 Zosano Pharma Corporation shares in Q3 2016, an estimated $528K.
Putnam Investments first reported a position in Zosano Pharma Corporation in Q1 2015 and held it in 6 quarters.
Putnam Investments's Zosano Pharma Corporation position peaked at $4.04M in Q1 2015.
14 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2016.

Based on Putnam Investments's 13F filing for Q3 2016, filed 14 Nov 2016.